Elevation of gangliosides in four brain regions from Parkinson’s disease patients with a GBA mutation
Abstract A number of genetic risk factors have been identified over the past decade for Parkinson’s Disease (PD), with variants in GBA prominent among them. GBA encodes the lysosomal enzyme that degrades the glycosphingolipid, glucosylceramide (GlcCer), with the activity of this enzyme defective in...
| الحاوية / القاعدة: | npj Parkinson's Disease |
|---|---|
| المؤلفون الرئيسيون: | , , , , , , , |
| التنسيق: | مقال |
| اللغة: | الإنجليزية |
| منشور في: |
Nature Portfolio
2022-08-01
|
| الوصول للمادة أونلاين: | https://doi.org/10.1038/s41531-022-00363-2 |